(OTCBB: IMGG.OB), (PINKSHEETS: IPXL), (OTCBB: IFMX.OB).

Turning Pennies into dollars: (OTCBB: IMGG.OB), (PINKSHEETS: IPXL), (OTCBB: IFMX.OB).

Are you a public company looking for exposure?
Contact RealPennies.com - 1.800.940.6559

For more info: http://imgg.realpennies.com

BURBANK, CA-Apr 14, 2008 - (OTCBB: IMGG.OB) Imaging3, Inc. , developer of the Dominion Vi Scanner, a breakthrough medical imaging device that produces 3D medical diagnostic images of virtually any part of the human body in real-time, will be the first company featured in the "Technology of the Day" section of www.jumpintotomorrow.com

Jumpintotomorrow.com is a site that lists, features and promotes the world's latest technological innovations across a broad spectrum of markets and uses. Imaging3 will be featured in the April 15, 2008 debut and launch of the site. The focus of the feature will be on the company's revolutionary 3D Volumetric Imaging Scanner technology.

According to Jumpintotomorrow.com's President and Founder, Sam Spear, "This site is dedicated to those who are driven to make a difference and have moved passed the thinking stage and who are actually doing, building and leading. Whether it's a breakthrough product or a breakthrough idea, what matters to us is that it's a breakthrough, period."

"We are pleased that our real-time 3D imaging platform is receiving this recognition and we're honored to be selected as the site's first Technology of the Day," states Dean Janes, Chairman and CEO of Imaging3, Inc. "The objective of Jumpintotomorrow.com is an important one and we wish Mr. Spear and his team the best of luck with their new venture," Mr. Janes added.

About Imaging3

Imaging3, Inc., founded in 1993, is a leading provider of advanced technology medical imaging devices. The Company has developed a breakthrough medical imaging device that produces 3D medical diagnostic images of virtually any part of the human body in real-time. Because these 3D images are instantly constructed in real-time, they can be used for any current or new medical procedures in which multiple frames of reference are required to perform medical procedures on or in the human body. Visit the company's website at www.imaging3.com

For more info: http://ipxl.realpennies.com

HAYWARD, Calif. APRIL 14, 2008- (PINKSHEETS: IPXL) IMPAX Laboratories, Inc. today announced that the Company has begun work to develop a next-generation carbidopa/levodopa product. The decision follows a meeting with the U.S. Food and Drug Administration to address the Agency’s previously disclosed concerns over product nomenclature and the potential for medication errors that might result from confusion of the Company’s Vadova® tablets with other marketed forms of carbidopa/levodopa. Following an extensive analysis by the Company and discussion with the FDA, IMPAX has decided to cease work with the current formulation of the product.

Michael Nestor, president of IMPAX’s Branded Products Division, commented, “Our R&D team, headed by Dr. Suneel Gupta, is at work on a next-generation carbidopa/levodopa product that will benefit from the regulatory experience and formulation experience we have gained through this process. In addition, we are prioritizing our other pipeline candidates. Our sales force has been establishing meaningful relationships in the marketplace since mid-2006, and we look to capitalize on those relationships with additional product offerings. We also are actively seeking in-licensing opportunities and other alliances to continue these valuable relationships. We remain fully committed to developing products that address critical patient needs in neurology and central nervous system indications.”

About IMPAX Laboratories, Inc.

IMPAX Laboratories, Inc. is a technology based specialty pharmaceutical company applying its formulation expertise and drug delivery technology to the development of controlled-release and specialty generics in addition to the development of branded products. IMPAX markets its generic products through its Global Pharmaceuticals division and markets its branded products through the IMPAX Pharmaceuticals division. Additionally, where strategically appropriate, IMPAX has developed marketing partnerships to fully leverage its technology platform. IMPAX Laboratories is headquartered in Hayward, California, and has a full range of capabilities in its Hayward and Philadelphia facilities. For more information, please visit the Company's Web site at: www.impaxlabs.com.

For more info: http://ifmx.realpennies.com

ROCKVILLE, Md., April 14 - (OTCBB: IFMX.OB) InforMedix Holdings, Inc. , announced that Boothwyn Pharmacy, a visionary pharmacy that sells medication adherence services to senior independent living centers, pharmaceutical companies, managed care organizations, and consumers, will be marketing and selling Med-ePhone and Med-eMonitor products and services to its existing client base. Boothwyn has pioneered the use of pharmacist consultants to provide medication adherence services, diabetes care products, durable medical equipment, and pharmaceutical compounding.

According to Louis Micolucci, President of Boothwyn Pharmacy, "We are excited to add the Med-ePhone and Med-eMonitor products to Boothwyn's ongoing services to improve medication adherence for senior citizens in independent living centers, women with high risk pregnancies monitored through pharmaceutical company programs, and managed care patients. These products from InforMedix will significantly increase the value of the services Boothwyn already offers under existing contracts with our customers, and should allow us to expand our business under new contracts. According to a report from MIT's Sloan School of Management, through improving its customers' medication adherence by 25%, a community pharmacy can increase gross revenues by $1.7 million and gross profits by $400,000 each year. We believe that through our aggressive marketing of InforMedix's products, that Boothwyn will significantly increase its revenues through the improved medication adherence of our customers, which will also further our mission of being at the forefront of improved communications methods to create greater patient outcomes."

Mr. Micolucci went on to state, "We are extremely impressed with the scientific studies validating InforMedix's Med-eXpert System, which links consumers, their loved ones, pharmacists, and care managers to improve medication adherence and health. We intend to distribute Med-ePhone and Med-eMonitor to our existing institutional customers and consumers, and then use these products along with other services we provide to expand our customer base. As a pharmacy that has pioneered methods to improve the care of our consumer customers and our institutional clients, we look forward to advancing this important tradition through our partnership with InforMedix."

Bruce A. Kehr, M.D, chairman and Chief Executive Officer of InforMedix commented, "We are extremely pleased to be partnering with Louis Micolucci and Boothwyn Pharmacy. Louis is a visionary pharmacy entrepreneur who has extended advanced medication adherence services well beyond his consumer base to a number of institutions. We are highly impressed with his business operation and facility, which is beautifully designed, and filled with contrasting symbols of pharmacy practice from past centuries and the high-tech self-care products of today."

About Boothwyn Pharmacy

Established in 1933, Boothwyn Pharmacy Inc., believes that the patient, doctor, pharmacist relationship is the cornerstone of quality healthcare. Services provided include retail prescriptions, customized compounded medications, institutional pharmaceutical needs for its geriatric population, and home health care medical equipment and supplies. Boothwyn Pharmacy, Inc. places itself at the forefront of bringing together innovative practices, state-of-the-art technology and improved communication methods to create greater patient outcomes. Additional services include the provision of pharmaceutical and medical supply services to retail customers as well as those patients with specialized needs in home-care or long-term care settings.

About InforMedix

InforMedix, Inc., "The Medication Adherence Solution," is based in Rockville, Maryland. The Company has brought to market its Med-eXpert System for consumer product and disease management markets, which use Med-ePhone and Med-eMonitor units to deliver peace-of-mind, improved independent living, and better health outcomes to patients and their loved ones. The Med-ePhone System prompts, monitors and records medication adherence and health status assessment delivered to patients over mobile phones and landlines using Interactive Voice Response Systems , combined with 24/7 monitoring. The Med-eMonitor System ) integrates a portable patient-interactive "smart pillbox," hardware, software, and 24/7 monitoring. Both products are designed to enable chronically ill patients and their loved ones, professionals in disease management programs, and medical researchers to efficiently monitor and manage medication and care plan adherence, clinical response, and drug safety. For more information, visit http://www.informedix.com.

Read our full disclaimer at: http://www.realpennies.com/start.html

Investors are advised that this analysis is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy. This report does not have regard to the specific investment objectives, financial situation and the particular needs of any specific person who may receive this information. The information contained herein is based on sources that we believe to be reliable but is not guaranteed by us as being accurate and does not purport to be a complete statement or summary of the available data. Past performance is no guarantee of future results. Please consult a broker before purchasing or selling any securities mentioned on RealPennies. For more movers: http://www.realpennies.com/wrapup.html

Any opinions expressed herein are statements of our judgment as of the date of publication and are subject to change without notice.
Sitemap: http://www.realpennies.com/sitemap.html

Sponsored by: http://www.isthemarketopen.com

RealPennies .

Telephone: 1-800-940-6559

Matt /at/ realpennies.com